← BackBrowse analysis archive →
Wall Street Moves on MAA, Rivian and Design Therapeutics: One Upgrade, One Target Trim and a Biotech on Watch
24/7 Wall Street · 78d ago · Sentiment -0.05
Read original ↗Impact scope
2 industries
direct 2·2nd-order 1
Top gainer
🔒
Top loser
🔒
Impact chainNews → industry → company, ranked top-down by impact
Pro only
Impact chains, crowding, market view and insider signals — try Pro free for 7 days when you sign up.
Start my free trial